HERON THERAPEUTICS, INC. /DE/ Restructuring Charges
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Restructuring Charges of $5.40 million for the 1-month period ending 2022-06-30, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-02-27
- HERON THERAPEUTICS, INC. /DE/ restructuring charges for fiscal 2020 was $5.60M.
| Period end | Restructuring Charges 1 month | Restructuring Charges 1 month as first filed | Restructuring Charges 12 month |
|---|---|---|---|
| 2022-06-30 | $5.40M 10-K · filed 2025-02-27 | $5.90M 10-Q · filed 2022-08-09 | |
| 2021-10-31 | $1.40M 10-K · filed 2023-03-29 | $1.60M 10-K · filed 2022-02-28 | |
| 2020-12-31 | $5.60M 10-K · filed 2022-02-28 | ||
| 2020-10-31 | $5.60M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |